SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Patient Versus Physician Valuation of Durable Survival Gains: Implications for Value Framework Assessments
16 references·0 citing·31 second hop
Patient Versus Physician Valuation of Durable Survival Gains: Implications for Value Framework Assessments (2017)Patient Versus Physician Valuation of Dur…Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received (2016)Updating the American Society…American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options (2015)American Society of Clinical …A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS) (2015)A standardised, generic, vali…Patient Preferences Versus Physicians’ Judgement: Does it Make a Difference in Healthcare Decision Making? (2013)Patient Preferences Versus Ph…Gender Differences in Risk Aversion and Ambiguity Aversion (2009)Gender Differences in Risk Av…Men, Women and Risk Aversion: Experimental Evidence (2008)Men, Women and Risk Aversion:…Chapter 113 Men, Women and Risk Aversion: Experimental Evidence (2008)Chapter 113 Men, Women and Ri…Risk Aversion and Incentive Effects (2002)Risk Aversion and Incentive E…Physician Agency (2000)Physician AgencyARE WOMEN MORE RISK AVERSE? (1998)ARE WOMEN MORE RISK AVERSE?Advances in prospect theory: Cumulative representation of uncertainty (1992)Advances in prospect theory: …Prospect theory: An analysis of decision under risk (1988)Prospect theory: An analysis …Prospect Theory: An Analysis of Decision under Risk (1979)Prospect Theory: An Analysis …Risk Aversion in the Small and in the Large (1976)Risk Aversion in the Small an…Risk Aversion in the Small and in the Large (1964)Risk Aversion in the Small an…The Utility Analysis of Choices Involving Risk (1948)The Utility Analysis of Choic…Developments in Non-Expected Utility Theory: The Hunt for a Descriptive Theory of Choice under Risk (2000)A domain‐specific risk‐attitude scale: measuring risk perceptions and risk behaviors (2002)Gender Differences in Preferences (2009)Beyond the Glass Ceiling: Does Gender Matter? (2011)Gender and Competition (2011)Judgment under Uncertainty: Heuristics and Biases (1975)Loss Aversion in Riskless Choice: A Reference-Dependent Model (1991)Individual differences in reasoning: Implications for the rationality debate? (2000)A perspective on judgment and choice: Mapping bounded rationality. (2003)Asset Allocation and Individual Risk Aversion (1992)Boys will be Boys: Gender, Overconfidence, and Common Stock Investment (2001)Financial Literacy, Financial Education, and Downstream Financial Behaviors (2014)Risk, Ambiguity, and the Savage Axioms (1961)The Framing of Decisions and the Psychology of Choice (1981)Exploration and Exploitation in Organizational Learning (1991)Explicating dynamic capabilities: the nature and microfoundations of (sustainable) enterprise performance (2007)Theory of games and economic behavior (2019)Net Health Benefits (1998)Projections of the Cost of Cancer Care in the United States: 2010-2020 (2011)The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient's Experience (2013)Essential medicines for universal health coverage (2016)Financial Hardships Experienced by Cancer Survivors: A Systematic Review (2016)Toward a positive theory of consumer choice (1980)Risk as feelings. (2001)Financial Intermediation and Delegated Monitoring (1984)Well-being : the foundations of hedonic psychology (1999)Oxytocin increases trust in humans (2005)INDIVIDUAL RISK ATTITUDES: MEASUREMENT, DETERMINANTS, AND BEHAVIORAL CONSEQUENCES (2011)On the measurement of inequality (1970)THE VALUATION OF RISK ASSETS AND THE SELECTION OF RISKY INVESTMENTS IN STOCK PORTFOLIOS AND CAPITAL BUDGETS**This paper is another in a series of interrelated theoretical and statistical studies of corporate financial and investment policies being made under grants from the Rockefeller Foundation, and more recently the Ford Foundation, to the Harvard Business School. The generous support for this work is most gratefully acknowledged. The author is also much indebted to his colleagues Professors Bishop, Christenson, Kahr, Raiffa, and (especially) Schlaifer, for extensive discussion and commentary on an earlier draft of this paper; but responsibility for any errors or imperfections remains strictly his own.[Professor Sharpe's paper, “Capital Asset Prices: A Theory of Market Equilibrium Under Conditions of Risk” (Journal of Finance, September 1964) appeared after this paper was in final form and on its way to the printers. My first section, which parallels the first half of his paper (with corresponding conclusions), sets the algebraic framework for sections II, III and VI, (which have no counterpart in his paper) and for section IV on the equilibrium prices of risk assets, concerning which our results differ significantly for reasons which will be explored elsewhere. Sharpe does not take up the capital budgeting problem developed in section V below.] (1975)The arbitrage theory of capital asset pricing (1976)
this work references cited by second hop

References

  • 1979Prospect Theory: An Analysis of Decision under Risk48,459 cited
  • 1988Prospect theory: An analysis of decision under risk32,475 cited
  • 1992Advances in prospect theory: Cumulative representation of uncertainty15,457 cited
  • 2002Risk Aversion and Incentive Effects5,973 cited
  • 1964Risk Aversion in the Small and in the Large4,964 cited
  • 1976Risk Aversion in the Small and in the Large4,655 cited
  • 1948The Utility Analysis of Choices Involving Risk3,097 cited
  • 1998ARE WOMEN MORE RISK AVERSE?1,777 cited
  • 2008Chapter 113 Men, Women and Risk Aversion: Experimental Evidence923 cited
  • 2015American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options916 cited
  • 2015A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)817 cited
  • 2008Men, Women and Risk Aversion: Experimental Evidence662 cited
  • 2009Gender Differences in Risk Aversion and Ambiguity Aversion657 cited
  • 2016Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received655 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2000Physician Agency583 cited
  • 2013Patient Preferences Versus Physicians’ Judgement: Does it Make a Difference in Healthcare Decision Making?216 cited
  • Cited by

    No citing works inside the corpus for this window.